Literature DB >> 12591525

Tautomycetin as a novel immunosuppressant in transplantation.

D J Han1, Y L Jeong, Y M Wee, A Y Lee, H K Lee, J C Ha, S K Lee, S C Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12591525     DOI： 10.1016/s0041-1345(02)03905-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  SHP2 is a target of the immunosuppressant tautomycetin.

Authors:  Sijiu Liu; Zhihong Yu; Xiao Yu; Sheng-Xiong Huang; Yinggang Luo; Li Wu; Weihua Shen; Zhenyun Yang; Lina Wang; Andrea M Gunawan; Rebecca J Chan; Ben Shen; Zhong-Yin Zhang
Journal:  Chem Biol       Date:  2011-01-28

Review 2.  Biosynthesis, regulation, and engineering of a linear polyketide tautomycetin: a novel immunosuppressant in Streptomyces sp. CK4412.

Authors:  Si-Sun Choi; Hee-Ju Nah; Hye-Rim Pyeon; Eung-Soo Kim
Journal:  J Ind Microbiol Biotechnol       Date:  2016-10-12       Impact factor: 3.346

3.  The synergistic effect of Tautomycetin on Cyclosporine A-mediated immunosuppression in a rodent islet allograft model.

Authors:  Yu-Mee Wee; Monica Young Choi; Choong-Hoon Kang; Yang-Hee Kim; Jin-Hee Kim; Sang-Kyou Lee; Seung-Young Yu; Song-Cheol Kim; Duck-Jong Han
Journal:  Mol Med       Date:  2010-04-30       Impact factor: 6.354

4.  Characterization of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis.

Authors:  Wenli Li; Jianhua Ju; Scott R Rajski; Hiroyuki Osada; Ben Shen
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.